New Kidney Transplant Drug Cuts Risk of Earlier Death: Study
Belatacept showed long-term benefits over older immune-suppressing drug, but costs moreContinue Reading
Belatacept showed long-term benefits over older immune-suppressing drug, but costs moreContinue Reading
New risk calculator estimates who will need dialysis in two to five yearsContinue Reading
But organ donors needn’t worry, researcher saysContinue Reading
But organ donors needn’t worry, researcher saysContinue Reading
While study can’t prove cause-and-effect, increasing damage seen as dose risesContinue Reading
Higher-than-normal blood sugar levels can lead to kidney failure over time, research saysContinue Reading
Getting levels below current targets may significantly cut risk of heart attack, stroke, researchers contendContinue Reading
And study found that more are developing kidney problems as a result of their diseaseContinue Reading
Data review finds organ availability, survival rates better for whitesContinue Reading
Dialysis, organ transplant may boost odds for certain types of cancerContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.